Trial Profile
Phase 1 multi-dose study of CAB-175 in patients with bacterial infection
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs CB 181963 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- 20 Jun 2016 New trial record